Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata: A Real-World Evidence ApproachRelease Date:Research Inflammation & Immunology USA Guideline Concordant Care and Emerging Data for Patients with MIBC through la/mUCEducation Oncology USA Advancing Genomic Competence and Patient Centered Care in Metastatic Breast CancerRelease Date:Education Oncology Canada, China, France, Germany, India, Italy, Japan, Spain, United Kingdom AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction ManagementRelease Date:Research Internal Medicine Australia, Canada, Germany, Greece, Japan, Korea, Taiwan Clinical Data Updates on Long Term Outcomes and Practical Therapy Management Strategies in First-line ALK-positRelease Date:Education Oncology United States Minor Outlying I OPTIMA-HEMA Project: Optimizing the Management and Application of Novel Immunotherapies in Hematologic MalignanciesRelease Date:Quality Improvement Oncology China Advancing Adult Immunization Strategies:A Focus on the Impact of Respiratory Syncytial Virus(RSV) and Cardiorespiratory OutcomeRelease Date:Education Vaccines USA Implementing Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease USA Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Fellowship Internal Medicine Germany Title Grant Type Focus Area Country Application Due Date Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)Release Date:Education Rare Disease USA Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CMRelease Date:Quality Improvement Rare Disease Canada Develop Young Physicians to Lead the Increase in Preventive Awareness by VaccinationRelease Date:Education Vaccines Japan Optimizing maternal immunization practice and vaccination access during pregnancy in ItalyRelease Date:Quality Improvement Vaccines Italy Projects for Enhancing Regional Cancer TreatmentRelease Date:Partner: Japanese Society of Clinical OncologyQuality Improvement Oncology Japan Sickle Cell Disease (SCD) FellowshipRelease Date:Fellowship Rare Disease USA Cancer RegistryRelease Date:Research Oncology Congo, The Democratic Republic The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic DermatitisRelease Date:Research Inflammation & Immunology China Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic DermatitisRelease Date:Research Inflammation & Immunology China Improving the Therapeutic Environment for Metastatic Breast CancerRelease Date:Education Oncology Japan Shared Decision-Making (SDM) in Lung CancerRelease Date:Education Oncology Japan Improving Care for Patients with Hodgkin and Non-Hodgkin’s LymphomaRelease Date:Education Oncology USA